Magle Chemoswed Holding Stock Key Fundamental Indicators
| MAGLE Stock | SEK 10.90 0.30 2.68% |
As of the 17th of February 2026, Magle Chemoswed secures the Mean Deviation of 2.77, risk adjusted performance of (0.17), and Standard Deviation of 3.75. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Magle Chemoswed Holding, as well as the relationship between them. Please verify Magle Chemoswed Holding information ratio, as well as the relationship between the value at risk and kurtosis to decide if Magle Chemoswed Holding is priced some-what accurately, providing market reflects its recent price of 10.9 per share.
Magle Chemoswed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Magle Chemoswed's valuation are provided below:Magle Chemoswed Holding does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Magle |
Magle Chemoswed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Magle Chemoswed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Magle Chemoswed.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Magle Chemoswed on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Magle Chemoswed Holding or generate 0.0% return on investment in Magle Chemoswed over 90 days. Magle Chemoswed is related to or competes with Mendus AB, Ascelia Pharma, Corline Biomedical, Elicera Therapeutics, Intervacc, Xintela AB, and Moberg Pharma. Magle Chemoswed Holding AB engages in the research, development, and manufacture of pharmaceutical products and technolo... More
Magle Chemoswed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Magle Chemoswed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Magle Chemoswed Holding upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 20.42 | |||
| Value At Risk | (8.22) | |||
| Potential Upside | 6.21 |
Magle Chemoswed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Magle Chemoswed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Magle Chemoswed's standard deviation. In reality, there are many statistical measures that can use Magle Chemoswed historical prices to predict the future Magle Chemoswed's volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.10) | |||
| Treynor Ratio | 1.51 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Magle Chemoswed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Magle Chemoswed February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.17) | |||
| Market Risk Adjusted Performance | 1.52 | |||
| Mean Deviation | 2.77 | |||
| Coefficient Of Variation | (459.50) | |||
| Standard Deviation | 3.75 | |||
| Variance | 14.03 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.10) | |||
| Treynor Ratio | 1.51 | |||
| Maximum Drawdown | 20.42 | |||
| Value At Risk | (8.22) | |||
| Potential Upside | 6.21 | |||
| Skewness | (0.12) | |||
| Kurtosis | 0.9105 |
Magle Chemoswed Holding Backtested Returns
Magle Chemoswed Holding has Sharpe Ratio of -0.22, which conveys that the firm had a -0.22 % return per unit of risk over the last 3 months. Magle Chemoswed exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Magle Chemoswed's Mean Deviation of 2.77, standard deviation of 3.75, and Risk Adjusted Performance of (0.17) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.55, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Magle Chemoswed are expected to decrease at a much lower rate. During the bear market, Magle Chemoswed is likely to outperform the market. At this point, Magle Chemoswed Holding has a negative expected return of -0.81%. Please make sure to verify Magle Chemoswed's total risk alpha, kurtosis, market facilitation index, as well as the relationship between the value at risk and rate of daily change , to decide if Magle Chemoswed Holding performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.73 |
Good predictability
Magle Chemoswed Holding has good predictability. Overlapping area represents the amount of predictability between Magle Chemoswed time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Magle Chemoswed Holding price movement. The serial correlation of 0.73 indicates that around 73.0% of current Magle Chemoswed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.73 | |
| Spearman Rank Test | 0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 5.98 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Magle Chemoswed Holding has a Return On Asset of 0.0251. This is 100.29% lower than that of the Healthcare sector and 100.11% lower than that of the Biotechnology industry. The return on asset for all Sweden stocks is 117.93% lower than that of the firm.
Magle Chemoswed Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Magle Chemoswed's current stock value. Our valuation model uses many indicators to compare Magle Chemoswed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Magle Chemoswed competition to find correlations between indicators driving Magle Chemoswed's intrinsic value. More Info.Magle Chemoswed Holding is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Magle Chemoswed Holding is roughly 2.42 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Magle Chemoswed's earnings, one of the primary drivers of an investment's value.Magle Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Magle Chemoswed's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Magle Chemoswed could also be used in its relative valuation, which is a method of valuing Magle Chemoswed by comparing valuation metrics of similar companies.Magle Chemoswed is currently under evaluation in return on asset category among its peers.
Magle Fundamentals
| Return On Equity | 0.0607 | |||
| Return On Asset | 0.0251 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 342.6 M | |||
| Shares Outstanding | 10.8 M | |||
| Shares Owned By Insiders | 78.60 % | |||
| Price To Earning | 133.33 X | |||
| Price To Book | 2.01 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 132.15 M | |||
| Gross Profit | 110.83 M | |||
| EBITDA | 18.14 M | |||
| Net Income | 4.19 M | |||
| Cash And Equivalents | 24.01 M | |||
| Cash Per Share | 2.40 X | |||
| Total Debt | 25.94 M | |||
| Debt To Equity | 0.30 % | |||
| Current Ratio | 1.94 X | |||
| Book Value Per Share | 13.71 X | |||
| Cash Flow From Operations | 26.04 M | |||
| Earnings Per Share | 0.91 X | |||
| Number Of Employees | 69 | |||
| Beta | 0.66 | |||
| Market Capitalization | 272.16 M | |||
| Total Asset | 237.18 M | |||
| Z Score | 6.0 | |||
| Net Asset | 237.18 M |
About Magle Chemoswed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Magle Chemoswed Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Magle Chemoswed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Magle Chemoswed Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Magle Chemoswed Holding AB engages in the research, development, and manufacture of pharmaceutical products and technology in Sweden. Magle Magle Chemoswed Holding AB is a subsidiary of Magle AB. Magle Chemoswed is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Magle Stock Analysis
When running Magle Chemoswed's price analysis, check to measure Magle Chemoswed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Magle Chemoswed is operating at the current time. Most of Magle Chemoswed's value examination focuses on studying past and present price action to predict the probability of Magle Chemoswed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Magle Chemoswed's price. Additionally, you may evaluate how the addition of Magle Chemoswed to your portfolios can decrease your overall portfolio volatility.